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Pregnancies with a male fetus are associated with higher risks of pregnancy complications through maladaptation of the maternal
immune system. The pathophysiology of this phenomenon is unknown. A possible pathway could be a fetal sex-dependent
maternal immune response, since males have a Y chromosome encoding speciﬁc allogenic proteins, possibly contributing to a
diﬀerent response and higher complication risks. To analyze whether fetal sex aﬀects mRNA expression of maternal immune
genes in early pregnancy, real-time PCR quantiﬁcation was performed in the decidual tissue from primigravid pregnancies
(n = 20) between 10 and 12 weeks with uncomplicated term outcomes. Early-pregnancy decidual mRNA expression of the
regulatory T-cell marker, FOXP3, was sixfold lower (p < 0 01) in pregnancies with a male fetus compared to pregnancies with a
female fetus. Additionally, mRNA expression of IFNγ was sixfold (p < 0 05) lower in pregnancies with a male fetus. The present
data imply maternal immunologic diﬀerences between pregnancies with male and female fetuses which could be involved in
diﬀerent pregnancy pathophysiologic outcomes. Moreover, this study indicates that researchers in reproductive immunology
should always consider fetal sex bias.
1. Introduction
Pregnancies with a male fetus have a higher incidence of
preterm birth, gestational diabetes mellitus, and preeclampsia
[1–4]. The pathophysiology of this phenomenon is unknown.
Since these complications of pregnancy are associated with
maladaptation of the maternal immune system [5], a possible
pathway could lie in a fetal sex-dependent maternal immune
response. An explanation might be found in the Y chromo-
some in males which encodes speciﬁc allogenic proteins, pos-
sibly contributing to a diﬀerent maternal immune response
when a male fetus is carried.
A number of studies have shown that the maternal
immune system develops a fetus-speciﬁc immune response
[6–8]. Moreover, studies demonstrated fetal sex-speciﬁc
cytokine levels in maternal peripheral blood during and after
pregnancy [9–11]. Additionally, fetal sex was found to aﬀect
cytokine expression in placental tissue in asthmatic pregnant
women [12, 13]. Until now, diﬀerences in the maternal
immune response between pregnancies with male or female
fetuses were only shown in the peripheral blood and postpar-
tum placental tissue. Whether a fetal sex-speciﬁc immune
response is elicited at the fetal-maternal interface already in
early pregnancy is unknown.
T-regulatory cells (Tregs) are of particular interest in
complicated as well as uncomplicated pregnancies because
of their immunosuppressive properties [14]. Tregs skew the
proinﬂammatory T-helper 1 response to the more tolerating
T-helper 2 response cells [14]. Adequate function and opti-
mal numbers of Tregs are essential for normal implantation
and pregnancy outcome, and a lack of adequate Treg num-
bers is associated with adverse pregnancy outcomes such as
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preeclampsia, implantation failure, and infertility [14–16].
The transcription factor forkhead box protein P3 (FOXP3)
has been identiﬁed as the immunosuppressive protein and
marker for Tregs [17]. Whether modulation of the Treg pop-
ulation is dependent on fetal sex and whether Tregs play a
role in the etiology of higher rates of pregnancy complica-
tions in pregnancies with a male fetus is unknown.
Besides Tregs, other immune cells such as macrophages
contribute to tolerance in early pregnancy by shifting
towards a more tolerating M2 phenotype and by releasing
cytokines which contribute to implantation and tissue
remodeling [18, 19]. Fetal sex-speciﬁc diﬀerences in activa-
tion and cytokine proﬁles of macrophages in placental tissue
were found in a mouse study [20]. Early-pregnancy alter-
ations in mRNA expression of macrophage-associated genes
in pregnancies with complicated outcomes were demon-
strated [21]. However, to our knowledge, neither human
studies nor early-pregnancy studies concerning sex-speciﬁc
macrophages have been performed.
T-lymphocytes and macrophages secrete cytokines
that contribute to either a proinﬂammatory or an
anti-inﬂammatory environment. Both pro- and anti-
inﬂammatory cytokines play a role in implantation, placenta-
tion, and pregnancy success [22]. Whereas IL1b and
interferon-γ (IFNɣ) secretion at the fetal-maternal interface
seems beneﬁcial for successful implantation [23], increased
levels of IL6 at term are associated with preterm delivery
and neonatal morbidity [24, 25]. Presumably, the timing
and amount of secretion determine whether a cytokine at
a certain stage of pregnancy is beneﬁcial for pregnancy
maintenance.
The aim of this study is to analyze fetal sex-dependent
diﬀerences in mRNA expression of maternal FOXP3, macro-
phage, and other immune-associated gene parameters at the
fetal-maternal interface in early pregnancies that developed
uneventfully. Hence, the unique ﬁrst-trimester decidual tis-
sue from ongoing human pregnancies with known uncom-
plicated term outcomes was studied.
2. Methods
First-trimester decidual tissue was obtained from surplus tis-
sue at vaginally sampled chorionic villus sampling (CVS),
between 10 and 12 weeks of gestation for maternal age (over
36 years of age at 18 weeks of gestation) screening for related
risk of aneuploidy following the protocol fromHuisman et al.
[26]. Karyotype analysis was performed for all samples, and
the karyogram appeared normal for all fetuses. Immediately
after sampling, the decidual tissue was microscopically sepa-
rated from the villi to minimize trophoblast contamination.
Subsequently, samples were stored until further analysis
following the protocol from Huisman et al. [26].
Patients were informed that otherwise discarded material
could be used for research according to the “Guideline Good
Use” by the FMWV committee (Federation of Medical Scien-
tiﬁc Associations). Follow-up of pregnancies was available by
questionnaires postpartum. Patients on medication, with a
history of smoking, diabetes mellitus, or other comorbidities
were excluded from the study.
Decidual tissues from 20 uncomplicated primiparous
pregnancies were randomly selected (10 boys and 10 girls)
(see Table 1). All women participating in this study were
truly primigravid, did not undergo assisted reproductive
techniques, and did not take any medication apart from folic
acid. Based on NanoDrop quantity analysis, 4 samples were
excluded (2 boys, 2 girls). RNA was isolated and puriﬁed;
QIAzol lysis reagent (Qiagen, USA) was added, and samples
were homogenized using a TissueLyser (Qiagen) (2 minutes,
50 Hertz). Thereafter, RNA was isolated using RNAeasy plus
mini-kit (Qiagen). cDNA was reverse transcribed using
Superscript-II Reverse Transcriptase kit (Invitrogen, USA).
Three housekeeper genes (HPRT, GAPDH, and ACTB) were
analyzed. HPRT was the most consistent in all samples and
was therefore used for analysis. mRNA expression of TBX21
(T-helper 1 (Th1) response), GATA3 (T-helper 2 (Th2)
response),RORC (T-helper 17 (Th17 response), FOXP3 (Treg
marker), Interleukin 6 (IL6), IL1b, interferon-γ (IFNɣ), CD68
(macrophage), IRF5 (M1 macrophages), and MRC1 (M2
macrophages) was analyzed using TaqMan On-Demand-
Gene-Expression Assays (Thermo Fisher, USA).
PCR reactions were performed in triplicates in a volume
of 10μL consisting of 14 ng RNA, Mastermix (Thermo
Fisher, USA), and RNA free water. Runs were performed
on a ViiA7 Real-time PCR System (Thermo Fisher, USA),
and mRNA data were normalized to HPRT mRNA expres-
sion using 2−ΔCt. Undetectable cycle threshold (Ct) values
(>40) were analyzed as maximum Ct value (40). Outliers
were excluded using Grubb’s test. For analysis, GraphPad
Prism version 5.04 for Microsoft Windows (GraphPad
Software, USA) was used. Diﬀerences between the groups
were evaluated using Mann–Whitney U test with Bonferroni
multiple comparison corrections. p values< 0.05 were con-
sidered statistically signiﬁcant.
3. Results and Discussion
In pregnancies with a male fetus, there was a sixfold signiﬁ-
cantly lower mRNA expression of FOXP3 (p < 0 01) com-
pared to pregnancies with a female fetus (see Figure 1). In
Table 1: Characteristics of patient groups.
Pregnancies with a
female fetus (n = 8)
Pregnancies with a
male fetus (n = 8)
At CVS
Maternal age (years) 37.4± 0.81 39.5± 0.46
Gestational age
(weeks)






40.5± 0.55 41.0± 0.60
Birth weight (grams) 3588± 120.42 3444± 149.41
Mean ± SEM: chorionic villus sampling; CVS: characteristics were compared
between groups using Mann–Whitney U test with Bonferroni multiple
comparison corrections.
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both human and murine studies, it has been shown that
Tregs play a role in healthy implantation and placental devel-
opment in early pregnancy [27, 28]. The lower expression of
FOXP3 in the ﬁrst-trimester decidual tissue from pregnancies
with a male fetus could imply an inferior maternal immune
tolerance in early pregnancies with a male fetus possibly con-
tributing to a higher risk of pregnancy complications [14].
An explanation for the fetal sex-speciﬁc diﬀerence in
mRNA expression of FOXP3 could be the presence of the Y
chromosome in males, which encodes minor histocompati-
bility antigens (HY) [29]. HY antigens are expressed in the
ﬁrst-trimester placental tissue and can be recognized by
maternal T-lymphocytes eliciting an HY-speciﬁc immune
response [11, 30, 31]. Only a limited number of studies are
performed on the ability of fetal HY antigens to induce or
suppress maternal FOXP3 mRNA expression and Treg cells
[32, 33]. Kahn et al. showed that HY induces an HY-
speciﬁc Treg population that contributes to tolerance in
mice; however, no comparison with HY absent pregnancies
(solely female fetuses) was made. Therefore, no conclusions
of the eﬀects of fetal sex on FOXP3 induction can be made
[33]. Our results show that mRNA expression of the Treg
marker FOXP3 is aﬀected by fetal sex; however, more
research is necessary to clarify the role of HY in the diﬀerence
of mRNA expression between pregnancies with a male and a
female fetus.
In addition, signiﬁcantly higher mRNA expression of
IFNγ (p < 0 05) was found in pregnancies with a female fetus
(see Figure 1). Many studies have associated increased IFNγ
in diﬀerent tissues with pregnancy complications such as
preeclampsia [34]. Therefore, this ﬁnding could appear con-
tradictory to the hypothesis in which male fetuses have a less
favorable maternal immune environment in pregnancy.
However, the proinﬂammatory cytokine, which is encoded
by the IFNγ gene, has also been shown to be favorable for
pregnancy [22, 35, 36]. Especially in early pregnancy, IFNγ
has been demonstrated to be important [22, 35, 36]. IFNγ
plays a role in implantation, placentation, and continuation
of pregnancy [22, 35, 36]. Higher decidual IFNγ at term
was associated with preeclampsia; however, women deliver-
ing preterm had lower IFNγ at midgestation compared to
women delivering at term [34, 37, 38]. These data imply that
IFNγ synthesis is beneﬁcial in early pregnancy to midgesta-
tion and is unfavorable for pregnancy success in the third
trimester [36]. Furthermore, IFNγ has been shown to be
indispensable for the conversion of non-Treg cells into Treg
cells [37, 38]. Since we found higher mRNA expression of
both IFNγ and FOXP3, it could be postulated that during
early pregnancy, the higher expression of IFNγ is necessary
for a robust implantation and placentation and that the pos-
sible compensatory higher expression of FOXP3 mRNA is
necessary to dampen the eﬀect of proinﬂammatory cytokines
for successful pregnancy outcome. Herewith, the diﬀerences
found in this study support the hypothesis that a diﬀerence
in maternal immune response depending on fetal sex plays
a role in the diﬀerent incidences of pregnancy complications
between pregnancies with a male or a female fetus. Our
ﬁndings are in line with previous studies which showed
altered fetal sex-speciﬁc cytokine levels in peripheral mater-
nal blood during pregnancy and in placental tissue after
delivery [9, 10, 12, 13].
In this study, no fetal sex-speciﬁc diﬀerences in mRNA
expression of macrophage markers were found (see
Figure 2). Macrophage mRNA expression is possibly not
inﬂuenced by fetal sex at this early stage of pregnancy, as in
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Figure 1: mRNA expression of T-lymphocyte markers and cytokines in the ﬁrst-trimester human decidual tissue. Data are mean± SEM
mRNA target gene expression normalized to housekeeper gene HPRT, in the decidual tissue from pregnancies with a female fetus (open
bars, n = 8) and pregnancies with a male fetus (black bars, n = 8). Comparison between groups was evaluated using Mann–Whitney U test
with Bonferroni multiple comparison corrections; ∗p < 0 05, ∗∗p < 0 01.
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in macrophage activation was seen in late pregnancy but not
in early-pregnancy placental tissue [20]. Or, alternatively,
our sample size is too small to detect these changes.
This study uses the ﬁrst-trimester decidual tissue from
pregnancies with uncomplicated outcomes, which is unique
and almost unobtainable. With the current knowledge on
risks of pregnancy complications caused by CVS and the
availability of alternative techniques [39], nowadays, CVS
is not routinely performed anymore. The ﬁrst-trimester
decidual tissue used in this study is therefore highly appreci-
ated and a unique possibility that enabled analysis of
immune parameters in early pregnancies with known out-
come. To limit the risks of pregnancy complications, the
tissue volume taken with CVS was reduced to the smallest
amount. The remaining tissue volume after diagnostic tests
was only suﬃcient for PCR analysis of the genes shown
and no further experiments could be performed. Therefore,
actual protein synthesis and cell quantiﬁcation were not
investigated in this study. However, the diﬀerences in
mRNA expression shown in this study do imply diﬀerences
in the maternal immune response between pregnancies with
a male and a female fetus. Further research is necessary to
elucidate whether the diﬀerent mRNA expression found
does coincide with protein expression and the immune envi-
ronment in early pregnancy.
In general, despite growing evidence showing the eﬀects
of fetal sex on the maternal immune response, still, most
studies performed in reproductive research do not consider
a fetal sex bias blurring their results. As this study shows that
the maternal immune response diﬀers depending on fetal sex,
we propose that fetal sex diﬀerences between groups should
always be considered.
4. Conclusions
In summary, this study shows fetal sex-speciﬁc diﬀerences in
mRNA expression of maternal immune factors in the ﬁrst-
trimester decidual tissue. Lower mRNA expression of FOXP3
and the proinﬂammatory cytokine encoding gene IFNγ was
found in uncomplicated pregnancies with a male fetus
compared to pregnancies with a female fetus. In the ﬁrst-
trimester decidual tissue studied, no diﬀerences for mRNA
expression of macrophage markers were found.
These ﬁndings imply a fetal sex-dependent maternal
immune response, which could be involved in the patho-
physiology responsible for the higher incidence of adverse
pregnancy outcomes in pregnancies with a male fetus. More-
over, this study supports that reproductive immunology
research should always consider fetal sex bias.
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